By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Transgenomic has signed a definitive agreement to acquire the genetic testing business of Clinical Data for approximately $15.4 million, the firms announced after the close of the market Monday.

The acquisition will provide Transgenomic with Clinical Data's portfolio of Familion genetic tests for cardiac syndromes and PGxPredict tests for predicting drug response, which are currently sold by its PGx Health division.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.